Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Age-dependent regulation of cell-mediated collagen turnover
Michael J. Podolsky, … , Claude Jourdan Le Saux, Kamran Atabai
Michael J. Podolsky, … , Claude Jourdan Le Saux, Kamran Atabai
Published April 21, 2020
Citation Information: JCI Insight. 2020;5(10):e137519. https://doi.org/10.1172/jci.insight.137519.
View: Text | PDF
Research Article Aging Pulmonology

Age-dependent regulation of cell-mediated collagen turnover

  • Text
  • PDF
Abstract

Although aging represents the most important epidemiologic risk factor for fibrotic disease, the reasons for this are incompletely understood. Excess collagen deposition in tissues is the sine qua non of tissue fibrosis and can be viewed as an imbalance between collagen production and collagen degradation. Yet we still lack a detailed understanding of the changes that take place during development, maturation, and aging in extracellular matrix (ECM) dynamics. Resolution of fibrosis is impaired in aging, and this impairment may explain why age is the most important risk factor for fibrotic diseases, such as idiopathic pulmonary fibrosis. However, ECM dynamics and impaired resolution of fibrosis in aging remain understudied. Here we show that cell-mediated collagen uptake and degradation are diminished in aged animals and this finding correlates with downregulation of the collagen endocytic receptor mannose receptor, C-type 2 (Mrc2). We identify myeloid zinc finger-1 as a potentially novel transcriptional regulator of Mrc2, and both this transcription factor and Mrc2 are downregulated in multiple tissues and organisms in an age-dependent manner. Thus, cell-mediated degradation of collagen is an essential process that promotes resolution of fibrosis, and impairment in this process contributes to age-related fibrosis.

Authors

Michael J. Podolsky, Christopher D. Yang, Carlos Lizama Valenzuela, Ritwik Datta, Steven K. Huang, Stephen L. Nishimura, Sarah L. Dallas, Paul J. Wolters, Claude Jourdan Le Saux, Kamran Atabai

×

Figure 4

MZF1 regulates MRC2 expression.

Options: View larger image (or click on image) Download as PowerPoint
MZF1 regulates MRC2 expression.
(A) Schematic of 2-kb region upstream of...
(A) Schematic of 2-kb region upstream of the human MRC2 transcriptional start site with the putative MZF1 binding sites marked by blue arrows. (B) ChIP-Seq data from Encode ENCSR298QUH surrounding MRC2 gene. Scale bar: original magnification, ×30. (C) Collagen uptake assay in U937 cells treated with shRNA targeting MZF1 (sh-MZF1) or MRC2 or a scrambled control; N = 7. (D) Western blot in U937 cells treated with sh-MZF1 versus scramble or sh-MRC2 control against MRC2 and MZF1; histone H3 is a loading control (representative of N = 2). (E) Q-RT-PCR for MRC2 in sh-MZF1 cells versus scramble or sh-MRC2 control; N = 5. (F) Schematic of MZF1 putative binding sites (blue arrows) corresponding to the 625-bp peak noted in B. (G) Luciferase activity in U2OS cells treated with luciferase vector with the 625 bp from F or same sequence with 2-bp mutations in MZF1 binding sites (mut-MRC2) as well as MZF1 overexpression vector or BFP control; N = 4. (H) Representative Western blot for MRC2 and MZF1 of whole-lung lysates from young or mature mice 11 days after treatment with bleomycin or saline control; n = 3–4; a mix of male and female mice were used; GAPDH is a loading control. Statistics: (C, E, G) ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts